Your session is about to expire
← Back to Search
Raman Spectroscopy
Raman Spectroscopy for Lung Cancer Detection
N/A
Recruiting
Research Sponsored by University Health Network, Toronto
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 year
Awards & highlights
Study Summary
This trial will test if a new technique could accurately detect cancerous lung tissue in lab samples. #cancerdetection
Who is the study for?
This trial is for adults over 18 who are scheduled for lobectomy surgery due to suspected or confirmed lung cancer. They must be able to consent and have a tumor larger than 1cm3. People with mucinous adenocarcinoma, those on neoadjuvant therapy, or with certain lung diseases other than COPD or ILD cannot join.Check my eligibility
What is being tested?
The study is testing the Sentry System's Raman spectroscopy technology on removed lung tissue during surgery to see if it can accurately identify cancerous areas in the lungs.See study design
What are the potential side effects?
Since this study involves ex vivo (outside of the body) analysis of lung tissue using Raman spectroscopy, there are no direct side effects from the intervention being tested.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 1 year
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 year
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
investigate the variability of the Raman spectra using data points ex vivo on recently excised lung tissue, with at least one third of spectra labeled as normal and cancerous based on subsequent histopathology assessment.
Trial Design
1Treatment groups
Experimental Treatment
Group I: Raman SpectroscopyExperimental Treatment1 Intervention
Acquiring Raman spectroscopy data points ex vivo on recently excised lung tissue
Find a Location
Who is running the clinical trial?
University Health Network, TorontoLead Sponsor
1,473 Previous Clinical Trials
484,955 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I am not currently receiving treatment before my main cancer treatment.I have been diagnosed with mucinous adenocarcinoma of the lung.I have a lung condition, but it's not COPD or ILD.My tumor is smaller than 1cm3.My surgery sample is too small for study requirements.I am 18 years old or older.I have been diagnosed with or suspected to have lung cancer.I am scheduled for surgery to remove a lobe of my lung.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
What is the recruitment rate for participants in this experiment?
"Affirmative. According to clinicaltrials.gov, the research project which was initially posted on September 1st 2023 is presently in search of volunteers. A total of 50 individuals need to be registered from a single medical centre."
Answered by AI
Is the research project currently recruiting participants?
"Affirmative, information hosted on clinicaltrials.gov affirms that this medical research is searching for participants and has been since January 9th of 2023. The experimental protocol was last edited on March 27th of the same year with a target recruitment size of 50 patients from one location."
Answered by AI
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger